Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

Neoplasia

Volumn 2, Issue 4, 2000, Pages 306-314

  Rubenstein, James L ^a   Kim, Jin ^b   Ozawa, Tomoko ^a   Zhang, Michael ^a   Westphal, Manfred ^c   Deen, Dennis F ^a   Shuman, Marc A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Angiogenesis; Apoptosis; Glioblastoma; Vascular cooption; Vascular endothelial growth factor

Indexed keywords

CD31 ANTIGEN; NEUTRALIZING ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0033822622     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900102     Document Type: Article

References (24)

1. Malignant glioma: Should chemotherapy be overthrown by experimental treatments?
2. The endothelial hyperplasia of the cerebral blood vessels with brain tumors and its sarcomatous transformation
3. Phase II trial of the anti-angiogenic agent thalidomide in patients with recurrent high-grade gliomas
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
6. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
7. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
8. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
9. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
10. Anti-angiogenesis treatment for gliomas: Transfer of anti-sense vascular endothelial growth factor inhibits tumor growth in vivo
11. Dominant negative inhibition of Flk- 1 suppresses the growth of many tumor types in vivo
12. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
13. Suppression of gioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
14. A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death
15. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
16. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
17. Humanization of the anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
18. Karyotype analyses of 20 human glioma cell lines
19. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
20. Anti-angiogenic therapy of transgenic mice impairs de novo tumor growth
21. Expression of integrin alpha V-beta 3 in small blood vessels of glioblastoma tumors
22. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue
23. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
24. Hypoxia- mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression